Abstract
  • Population : Immunocompetent individuals living in JE-endemic areas
  • Intervention: One dose of live recombinant JE vaccine
  • Comparison: Placebo/no vaccination/other JE vaccine
  • Outcome : Serious adverse events
  • GRADE table
  • AEFI
  • Japanese encephalitis